Abraxis BioScience Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 333.7 | 765.5 | 518.8 |
| Cost of Goods Sold | 34.5 | 307.5 | 225.9 |
| Gross Profit | 299.2 | 458.0 | 292.9 |
| Gross Profit Margin | 89.7% | 59.8% | 56.5% |
| SG&A Expense | 308.2 | 377.4 | 146.5 |
| Depreciation & Amortization | 49.1 | 79.7 | 16.1 |
| Operating Income | (58.1) | 0.9 | 130.3 |
| Operating Margin | -- | 0.1% | 25.1% |
| Nonoperating Income | 5.0 | 4.0 | 2.4 |
| Nonoperating Expenses | 0.2 | 13.9 | 0.7 |
| Income Before Taxes | (49.6) | (17.6) | 133.9 |
| Income Taxes | (7.9) | 29.3 | 47.5 |
| Net Income After Taxes | (41.6) | (46.9) | 86.4 |
| Continuing Operations | (41.6) | (46.9) | 86.4 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (41.6) | (46.9) | 86.4 |
| Total Net Income | (41.6) | (46.9) | 86.4 |
| Net Profit Margin | -- | -- | 16.7% |
| Diluted EPS from Total Net Income ($) | (1.04) | (0.30) | 1.17 |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
